G-BA Innovation Committee announced funding of 18 new projects in Germany

02

May 2022

On April 4, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) announced funding from the G-BA Innovation Fund for 18 innovative healthcare research projects dedicated to medical guidelines.

In this cycle, 31 applications were received, and the selection was made based on the recommendations from the pool of experts and the Working Group of Scientific Medical Societies (AWMF). The selected projects are divided into the following way:

  • Healthcare in rare diseases: 4;
  • Healthcare in more common diseases, treatment of risk factors for non-communicable diseases, multimorbidity and improvement of drug therapy safety in healthcare: 8;
  • Healthcare for target groups with special needs, such as children, young people, the elderly, and/or people in need of care: 5;
  • Surgical interventions on the skeletal system/locomotor system: 1.

The overview of the new projects is expected to be published on the Innovation Committee's website in May 2022.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

06

Jun 2023

Director of MTRC Oleg Borisenko participated in the session “Innovative Payment Schemes (IPSs) in Europe: springboard for innovation?” at the Med Tech Forum in Dublin on the 31st of May 2023. The section was moderated by Rachele Busca (Director, HTA and Real-World Evidence, EMEACLA, Edwards Lifesciences) and panelists included Daniel Bamford (Deputy Director, Medtech and Digital, Innovation, Research and Life Sciences, NHS England) and Louisa Stüwe (Ministerial eHealth Delegation, Ministry of Health and Prevention, France). Oleg presented the summary of the report on innovative payment schemes for medical technologies, commissioned in 2022 by the European industry association Med Tech Europe to MTRC. We present a summary of the presentation.

Read more

02

Jun 2023

On May 15, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the decisions, recommending the transfer to standard care for another three completed projects. The projects relate to controlling drug prescriptions in outpatient settings, evaluating the effectiveness of outpatient extensive stuttering therapy in primary school children, and the efficacy of cross-sectoral care models in psychiatry.

Read more

30

May 2023

On April 5, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) announced the selection of thirty-five applications for Innovation Funding of healthcare research projects were accepted. A total of 231 applications were received in response to the funding announcement of June 27, 2022 (changed on September 20, 2022), and thirty-five of them were accepted.

Read more

24

May 2023

Between late April and May 2023, three more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, 47 health apps are currently available in the DiGA Directory, and six health apps were delisted from the Directory.

Read more

09

May 2023

On April 20, 2023, the Dutch Healthcare Authority (NZa) published the first release of the DRG package for 2024 (RZ24a). Twenty-three new procedure codes, nine new supplementary payments, and thirteen new DRGs will be implemented across gynecology, pulmonary, extracorporeal treatments, and other technology groups.

Read more